je.st
news
ARCA Biopharma Announces Health Canada Acceptance Of Genetic-AF Clinical Trial Application
2014-09-03 11:53:10| drugdiscoveryonline Home Page
ARCA biopharma, Inc. a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, recently announced that the Company’s Clinical Trial Application (CTA) for the GENETIC-AF clinical trial evaluating GencaroTM as a potential treatment for atrial fibrillation (AF) has been accepted by Health Canada
Tags: health
canada
application
trial
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||